Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Section 4.1 of the license agreement

Yes I believe it is a lump sum, but why go to the trouble of creating clauses that define ongoing royalty agreements, have them signed, and then simply delete them in an addendum. Why not just eliminate them from the agreement in the first place.

Share
New Message
Please login to post a reply